These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33072871)

  • 21. Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports.
    Thabrani A; Hadi WS; Thobari JA; Novianti Z; Kurniyanto ; Juliana I; Suharto A; Danaswari AN; Septiani I; Rhatomy S
    Ann Med Surg (Lond); 2021 Jun; 66():102444. PubMed ID: 34094533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis.
    Klassen SA; Senefeld J; Johnson PW; Carter RE; Wiggins CC; Shoham S; Grossman BJ; Henderson JP; Musser JM; Salazar E; Hartman WR; Bouvier NM; Liu STH; Pirofski LA; Baker SE; Van Helmond N; Wright RS; Fairweather D; Bruno KA; Paneth NS; Casadevall A; Joyner MJ
    medRxiv; 2021 Feb; ():. PubMed ID: 33140056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Transient Effect of Convalescent Plasma Therapy in a Patient with Severe Covonavirus Disease 2019: A Case Report.
    Baek AR; Choo EJ; Kim JY; Ha TS; Park SW; Shin HB; Park SK; Park JH; Kim T
    Infect Chemother; 2022 Sep; 54(3):553-558. PubMed ID: 35920265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review.
    Casman C; Fitriani N; Gunawan D; Rohayati R
    Florence Nightingale J Nurs; 2022 Oct; 30(3):301-309. PubMed ID: 36106813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms.
    Bruiners N; Guerrini V; Ukey R; Dikdan R; Yang J; Mishra PK; Onyuka A; Handler D; Vieth J; Carayannopulos M; Guo S; Pollen M; Pinter A; Tyagi S; Feingold D; Philipp C; Libutti S; Gennaro ML
    medRxiv; 2022 Feb; ():. PubMed ID: 35132422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran.
    Iranijam E; Ghobadi H; Matin S; Habibzadeh S; Zandian H; Mohammadshahi J; Fooladi S; Dargahi A; Safarzadeh E; Negaresh M; Hosseini J; Samadi AH; Hoseininia S; Salehzadeh H; Dezhkam S
    J Educ Health Promot; 2022; 11():266. PubMed ID: 36325204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective study shows that early administration of convalescent plasma in hospitalized COVID-19 patients may have a positive effect on disease progression.
    Birschmann I; von Bargen K; Teune M; Flottmann C; Knüttgen F; Knabbe C
    Health Sci Rep; 2022 Sep; 5(5):e714. PubMed ID: 35957967
    [No Abstract]   [Full Text] [Related]  

  • 28. WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
    Franchini M; Casadevall A; Joyner MJ; Focosi D
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.
    Das SK; Ranabhat K; Bhattarai S; Karki KB; Gyanwali P; Paneru HR; Nepal B; Dumre SP; Acharya SP
    Clin Case Rep; 2021 Apr; 9(4):2132-2137. PubMed ID: 33821192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Development of Ecchymosis after Administration of Convalescent Serum in a Patient with COVID-19 Associated with Thrombocytosis.
    Khot R; Kumbhalkar SD; Juneja R; Joshi PP
    Eur J Case Rep Intern Med; 2021; 8(9):002782. PubMed ID: 34671574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescents as partners in the fight against COVID-19.
    Kest H; Kaushik A; Jagunla A; Shaheen S; Zaveri S; Fernandez N; Gupta S; Goldberg D
    Int J Pediatr Adolesc Med; 2022 Jun; 9(2):113-116. PubMed ID: 34725643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection.
    Fodor E; Müller V; Iványi Z; Berki T; Kuten Pella O; Hornyák I; Ambrus M; Sárkány Á; Skázel Á; Madár Á; Kardos D; Kemenesi G; Földes F; Nagy S; Matusovits A; Nacsa J; Tordai A; Jakab F; Lacza Z
    Infect Dis Ther; 2022 Aug; 11(4):1767-1768. PubMed ID: 35575975
    [No Abstract]   [Full Text] [Related]  

  • 33. The emergency use authorization for COVID-19 convalescent plasma reduced mortality.
    Paneth N; Casadevall A; Joyner M
    Health Sci Rep; 2023 Aug; 6(8):e1463. PubMed ID: 37554952
    [No Abstract]   [Full Text] [Related]  

  • 34. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy.
    Franchini M; Marano G; Velati C; Pati I; Pupella S; Maria Liumbruno G
    Vox Sang; 2021 Jan; 116(1):136-137. PubMed ID: 32324899
    [No Abstract]   [Full Text] [Related]  

  • 35. Correction to: Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State.
    Lab Med; 2022 Nov; 53(6):651. PubMed ID: 35993399
    [No Abstract]   [Full Text] [Related]  

  • 36. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).
    Agarwal A; Mukherjee A; Kumar G; Chatterjee P; Bhatnagar T; Malhotra P;
    BMJ; 2020 Oct; 371():m3939. PubMed ID: 33093056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma.
    Gemici A; Bilgen H; Erdoğan C; Kansu A; Olmuşçelik O; Beköz HS; Çakmak R; Mert A; Sevindik ÖG
    Turk J Med Sci; 2020 Dec; 50(8):1781-1785. PubMed ID: 33078604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients.
    Pal P; Ibrahim M; Niu A; Zwezdaryk KJ; Tatje E; Robinson WR; Ko L; Satyavarapu I; Jones WE; Nachabe A; Luk A; Mushatt DM; Halvorson K; Denson JL; Smith CC; Simeone F; Davis G; Gill SK; McDougal A; Vigh AS; Peterson TG; Ning B; Hu T; Socola F; Robinson J; Safah H; Saba NS
    Transfus Med; 2021 Jun; 31(3):217-220. PubMed ID: 33073895
    [No Abstract]   [Full Text] [Related]  

  • 39. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
    Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
    Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convalescent plasma is ineffective for covid-19.
    Pathak EB
    BMJ; 2020 Oct; 371():m4072. PubMed ID: 33093025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.